- Home
- ISTR vs ATAI Comparison
ISTR vs ATAI Comparison
Compare ISTR & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISTR
- ATAI
- Stock Information
- Founded
- ISTR 2006
- ATAI 2018
- Country
- ISTR United States
- ATAI Germany
- Employees
- ISTR N/A
- ATAI N/A
- Industry
- ISTR Major Banks
- ATAI Biotechnology: Pharmaceutical Preparations
- Sector
- ISTR Finance
- ATAI Health Care
- Exchange
- ISTR Nasdaq
- ATAI Nasdaq
- Market Cap
- ISTR 229.3M
- ATAI 214.8M
- IPO Year
- ISTR 2014
- ATAI 2021
- Fundamental
- Price
- ISTR $23.39
- ATAI $1.52
- Analyst Decision
- ISTR
- ATAI Strong Buy
- Analyst Count
- ISTR 0
- ATAI 4
- Target Price
- ISTR N/A
- ATAI $9.00
- AVG Volume (30 Days)
- ISTR 35.1K
- ATAI 2.2M
- Earning Date
- ISTR 10-21-2024
- ATAI 11-13-2024
- Dividend Yield
- ISTR 1.79%
- ATAI N/A
- EPS Growth
- ISTR N/A
- ATAI N/A
- EPS
- ISTR 1.79
- ATAI N/A
- Revenue
- ISTR $82,729,000.00
- ATAI $331,000.00
- Revenue This Year
- ISTR N/A
- ATAI $44.72
- Revenue Next Year
- ISTR $12.80
- ATAI N/A
- P/E Ratio
- ISTR $13.01
- ATAI N/A
- Revenue Growth
- ISTR N/A
- ATAI N/A
- 52 Week Low
- ISTR $10.34
- ATAI $1.03
- 52 Week High
- ISTR $24.26
- ATAI $2.85
- Technical
- Relative Strength Index (RSI)
- ISTR 64.33
- ATAI 57.65
- Support Level
- ISTR $22.87
- ATAI $1.53
- Resistance Level
- ISTR $23.67
- ATAI $1.95
- Average True Range (ATR)
- ISTR 0.66
- ATAI 0.20
- MACD
- ISTR -0.04
- ATAI 0.03
- Stochastic Oscillator
- ISTR 75.98
- ATAI 52.22
About ISTR Investar Holding Corporation
Investar Holding Corp is a us-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.